Correcting the NLRP3 inflammasome deficiency in macrophages from autoimmune NZB mice with exon skipping antisense oligonucleotides

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Immunology and Cell Biology

• Publication date

  2016-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/icb.2016.3PMID 26833024
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deficient NLRP3 and AIM2 Inflammasome Function in Autoimmune NZB Mice

  2015cited by this paper
• In Silico Screening Based on Predictive Algorithms as a Design Tool for Exon Skipping Oligonucleotides in Duchenne Muscular Dystrophy

  2015cited by this paper
• A Sensitive Assay System To Test Antisense Oligonucleotides for Splice Suppression Therapy in the Mouse Liver

  2014cited by this paper
• Antisense-mediated exon skipping: taking advantage of a trick from Mother Nature to treat rare genetic diseases.

  2014cited by this paper
• Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy

  2013cited by this paper
• AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC

  2013cited by this paper
• Of inflammasomes and pathogens – sensing of microbes by the inflammasome

  2013cited by this paper
• The Lbw2 Locus Promotes Autoimmune Hemolytic Anemia

  2012cited by this paper
• The mammalian PYHIN gene family: Phylogeny, evolution and expression

  2012cited by this paper
• Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

  2011cited by this paper
• Loss of exon identity is a common mechanism of human inherited disease.

  2011cited by this paper
• Exonic Sequences Provide Better Targets for Antisense Oligonucleotides Than Splice Site Sequences in the Modulation of Duchenne Muscular Dystrophy Splicing

  2010cited by this paper
• Dystrophin isoform induction in vivo by antisense-mediated alternative splicing.

  2010cited by this paper
• Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms.

  2009cited by this paper
• Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica

  2008cited by this paper
• The influence of antisense oligonucleotide length on dystrophin exon skipping.

  2007cited by this paper
• Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications.

  2007cited by this paper
• Cryopyrin activates the inflammasome in response to toxins and ATP

  2006cited by this paper
• CpG DNA Activates Survival in Murine Macrophages through TLR9 and the Phosphatidylinositol 3-Kinase-Akt Pathway1

  2006cited by this paper
• Variation in sequence and organization of splicing regulatory elements in vertebrate genes.

  2004cited by this paper
• Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.

  2003cited by this paper
• Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing

  2003cited by this paper
• Predictive Identification of Exonic Splicing Enhancers in Human Genes

  2002cited by this paper
• The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.

  2002cited by this paper
• Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing.

  2000cited by this paper
• Association of intron phases with conservation at splice site sequences and evolution of spliceosomal introns.

  1999cited by this paper
• Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production

  1997cited by this paper
• Functional analysis of the polypyrimidine tract in pre-mRNA splicing.

  1997cited by this paper
• Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production.

  1997cited by this paper
• Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction.

  1993cited by this paper
• A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

  1992cited by this paper
• The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences

  1992cited by this paper
• The pathogenesis of autoimmunity in New Zealand mice.

  1990cited by this paper
• The pathogenesis of autoimmunity in New Zealand mice.

  1990cited by this paper
• F4/80, a monoclonal antibody directed specifically against the mouse macrophage

  1981cited by this paper
• Serveur Académique Lausannois SERVAL serval.unil.ch

  year unknowncited by this paper
• Predictive Identification of Exonic Splicing Enhancers in Human Genes

  year unknowncited by this paper

• Cola acuminata extract’s inhibition of NLRP3 inflammasome in THP-1 cells as a potential treatment option for Parkinson’s disease

  2025cites this paper
• Glabridin Inhibits Aspergillus fumigatus Growth and Alleviate Inflammation Mediated by Dectin-2 and NLRP3 Inflammasome

  2023cites this paper
• RNA metabolism and links to inflammatory regulation and disease

  2021cites this paper
• Inflammasomes: Pandora’s box for sepsis

  2018cites this paper
• Compromised NLRP3 and AIM2 inflammasome function in autoimmune NZB/W F1 mouse macrophages

  2018cites this paper
• Wnt5a contributes to dectin-1 and LOX-1 induced host inflammatory response signature in Aspergillus fumigatus keratitis.

  2018cites this paper
• Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease

  2017cites this paper
• Distribution and Penetration of Intracerebroventricularly Administered 2′OMePS Oligonucleotide in the Mouse Brain

  2017cites this paper